Sample Orthopaedic Oncology Digest

Sent Sunday, November 8, 2026 · All specialties

This is a real Orthopaedic Oncology issue of The Reduction, built from the newest orthopaedic literature — subscribers get one like it in their inbox. Subscribe to get your own, or browse the Orthopaedic Oncology archive.

The ReductionSunday, November 8, 2026

Recent

Journal of Surgical OncologyNov 02 2026
In 74 limb-sparing sarcoma patients, wound-healing events occurred in 61% (22% needing reoperation) and were associated with worse patient-reported physical and mental recovery at 3 months…
Orthopaedic Oncology
The Bone & Joint JournalNov 01 2026
In 137 limb dedifferentiated liposarcoma patients, those with positive margins confined to the low-grade component and no radiation had no recurrences or metastases, suggesting marginal excision…
Orthopaedic Oncology
Clinical Orthopaedics and Related ResearchOct 09 2026
In extremity osteosarcoma, 58% of indeterminate pulmonary nodules progressed and 25% became confirmed metastases; no nodule feature predicted progression, but these patients had worse 2-year survival…
Orthopaedic OncologyPediatric Orthopaedics

Classic

Journal of Bone and Joint Surgery (American)1987 · Cited by 1,492
In 280 patients with giant-cell tumor of bone, local recurrence was far lower after wide/radical resection (0%) than marginal (8%) or intralesional (27%) surgery, supporting more aggressive excision.
Orthopaedic Oncology

Review

JBJS ReviewsMar 2020
Radiographs remain the key first step in bone tumor assessment, allowing accurate diagnosis in over 80% of cases, with CT and MRI adding value for typical lesions, extent, and surgical planning.
Orthopaedic Oncology

Home  ·  All specialties  ·  Archive  ·  Subscribe

© 2026 The Reduction